The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
The molecular mechanisms of chemoresistance in cancers
Open accessAbstract
// Hua-Chuan Zheng 1 1 Department of Experimental Oncology and Animal Center, Shengjing Hospital of China Medical University, Shenyang 110004, China Correspondence to: Hua-Chuan Zheng, email: zheng_huachuan@hotmail.com Keywords: cancer, chemoresistance, molecular mechanisms, chemotherapy Received: March 31, 2017 Accepted: June 24, 2017 Published: July 06, 2017 ABSTRACT Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer patients because chemoresistance causes recurrence, cancer dissemination and death. This review summarizes numerous molecular aspects of multi-resistance, including transporter pumps, oncogenes (EGFR, PI3K/Akt, Erk and NF-κB), tumor suppressor gene (p53), mitochondrial alteration, DNA repair, autophagy, epithelial-mesenchymal transition (EMT), cancer stemness, and exosome. The chemoresistance-related proteins are localized to extracellular ligand, membrane receptor, cytosolic signal messenger, and nuclear transcription factors for various events, including proliferation, apoptosis, EMT, autophagy and exosome. Their cross-talk frequently appears, such as the regulatory effects of EGFR-Akt-NF-κB signal pathway on the transcription of Bcl-2, Bcl-xL and survivin or EMT-related stemness. It is essential for the realization of the target, individualized and combine therapy to clarify these molecular mechanisms, explore the therapy target, screen chemosensitive population, and determine the efficacy of chemoreagents by cell culture and orthotopic model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Zhang, J., Xu, Y., Gao, Y., Chen, C., Zheng, Z.-S., Yun, M., Weng, H.-W., Xie, D., & Ye, S. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0586-y · Cited by 88
RetractedMiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma
Pan, B., Feng, B., Chen, Y., Huang, G., Wang, R. Y., Chen, L., & Song, H. (2015) · Oncotarget · doi:10.18632/oncotarget.5352 · Cited by 74
RetractedYu, X., Du, J., Fan, Y.-J., Liu, F., Cao, L., Liang, N., Xu, D., & Zhang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12718 · Cited by 41
RetractedNANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
Qin, S., Li, Y., Cao, X., Du, J., & Huang, X. (2016) · Bioscience Reports · doi:10.1042/bsr20160247 · Cited by 37
RetractedOverexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
NF-kB in development and progression of human cancer
Dolcet, X., Llobet, D., Pallares, J., & Matias-Guiu, X. (2005) · Virchows Archiv · doi:10.1007/s00428-005-1264-9 · Cited by 1,169
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
Richards, K. E., Zeleniak, A. E., Fishel, M. L., Wu, J., Littlepage, L. E., & Hill, R. (2017) · Oncogene · doi:10.1038/onc.2016.353 · Cited by 735
Wei, Y., Zou, Z., Becker, N., Anderson, M., Sumpter, R., Xiao, G., Kinch, L., Koduru, P., Christudass, C. S., Veltri, R. W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.015 · Cited by 505
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 398
Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
Zhou, Y., Tozzi, F., Chen, J., Fan, F., Xia, L., Wang, J., Gao, G., Zhang, A., Xia, X., Brasher, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1674 · Cited by 374
Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D'Ilio, S., Lugini, L., Violante, N., Azzarito, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088193 · Cited by 354
Hu, Y., Yan, C., Mu, L., Huang, K., Li, X., Tao, D., Wu, Y., & Qin, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125625 · Cited by 348
Mitochondria and cancer chemoresistance
Guerra, F., Arbini, A. A., & Moro, L. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.012 · Cited by 323
Samudio, I., Fiegl, M., & Andreeff, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3722 · Cited by 308
The epidermal growth factor receptor mediates radioresistance
Liang, K., Ang, K. K., Milas, L., Hunter, N., & Fan, Z. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00511-x · Cited by 292
Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)
Deeley, R. G., & Cole, S. P. C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.036 · Cited by 284
Song, S., Honjo, S., Jin, J., Chang, S.-S., Scott, A. W., Chen, Q., Kalhor, N., Correa, A. M., Hofstetter, W. L., Albarracin, C. T., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2191 · Cited by 269
Monte, M., Simonatto, M., Peche, L. Y., Bublik, D. R., Gobessi, S., Pierotti, M. A., Rodolfo, M., & Schneider, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510834103 · Cited by 257
Hayakawa, J., Ohmichi, M., Kurachi, H., Kanda, Y., Hisamoto, K., Nishio, Y., Adachi, K., Tasaka, K., Kanzaki, T., & Murata, Y. (2000) · PubMed · Cited by 243
Ahmed, N., Abubaker, K., Findlay, J., & Quinn, M. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791190175 · Cited by 234
Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer
Ji, R., Zhang, B., Zhang, X., Xue, J., Yuan, X., Yan, Y., Wang, M., Zhu, W., Qian, H., & Xu, W. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1005530 · Cited by 233
Wickström, M., Dyberg, C., Milosevic, J., Einvik, C., Calero, R., Sveinbjörnsson, B., Sandén, E., Darabi, A., Siesjö, P., Kool, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms9904 · Cited by 229
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Brasseur, K., Gévry, N., & Asselin, E. (2017) · Oncotarget · doi:10.18632/oncotarget.14021 · Cited by 224
Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
Page, C., Lin, H., Jin, Y. H., et al. (2000) · PubMed · Cited by 220
Yu, H., Ai, Y., Yu, L., Zhou, X., Liu, J., Li, J., Xu, X., Liu, S., Chen, J., Liu, F., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23049 · Cited by 203
Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells
Song, J., Qu, Z., Guo, X., Zhao, Q., Zhao, X., Gao, L., Sun, K., Shen, F., Wu, M., & Wei, L. (2009) · Autophagy · doi:10.4161/auto.5.8.9996 · Cited by 195
McNeil, E. M., & Melton, D. W. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks818 · Cited by 190
Exosomes in tumor microenvironment: novel transporters and biomarkers
Wang, Z., Chen, J.-Q., Liu, J.-L., & Tian, L. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1056-9 · Cited by 180
Oliva, C. R., Moellering, D. R., Gillespie, G. Y., & Griguer, C. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024665 · Cited by 163
GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
Kim, M., Jung, J.-Y., Choi, S., Lee, H., Morales, L. D., Koh, J.-T., Kim, S. H., Choi, Y.-D., Choi, C., Slaga, T. J., et al. (2017) · Autophagy · doi:10.1080/15548627.2016.1239676 · Cited by 160
Lu, C., & Shervington, A. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9722-8 · Cited by 159
Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs
Chen, W., Cai, Y.-Q., Lv, M., Chen, L., Zhong, S., Ma, T.-F., Zhao, J., & Tang, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2242-0 · Cited by 158
Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy
Shteingauz, A., Boyango, I., Naroditsky, I., Hammond, E., Gruber, M., Doweck, I., Ilan, N., & Vlodavsky, I. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0037 · Cited by 156
Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis
Ojha, R., Bhattacharyya, S., & Singh, S. K. (2015) · BioResearch open access · doi:10.1089/biores.2014.0035 · Cited by 152
Kreger, B. T., Johansen, E., Cerione, R. A., & Antonyak, M. A. (2016) · Cancers · doi:10.3390/cancers8120111 · Cited by 152
Miao, Y., Zheng, W., Li, N., Su, Z., Zhao, L., Zhou, H., & Li, J. (2017) · Scientific Reports · doi:10.1038/srep41942 · Cited by 150
Wu, J., Ru, N.-Y., Zhang, Y., Li, Y., Wei, D., Ren, Z., Huang, X.-F., Chen, Z.-N., & Bian, H. (2011) · Oncogene · doi:10.1038/onc.2011.149 · Cited by 147
Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y., den Eynde, K. V., den broeck, A. V., Verhulst, S., Dollé, L., Gremeaux, L., Ceulemans, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.011 · Cited by 136
Bcl-2 family proteins: master regulators of cell survival
Hatok, J., & Račay, P. (2016) · BioMolecular Concepts · doi:10.1515/bmc-2016-0015 · Cited by 136
DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme
Nagel, Z. D., Kitange, G. J., Gupta, S. K., Joughin, B. A., Chaim, I. A., Mazzucato, P., Lauffenburger, D. A., Sarkaria, J. N., & Samson, L. D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1151 · Cited by 131
Tan, Q., Wang, H., Hu, Y., Hu, M., Li, X., Aodengqimuge, Yuan-fang Ma, A., Wei, C., & Song, L. (2015) · Cancer Science · doi:10.1111/cas.12712 · Cited by 120
Masciarelli, S., Fontemaggi, G., Di Agostino, S., Donzelli, S., Carcarino, E., Strano, S., & Blandino, G. (2014) · Oncogene · doi:10.1038/onc.2013.106 · Cited by 118
Cai, J., Wang, J., Huang, Y., Wu, H., Xia, T., Xiao, J., Chen, X., Li, H., Qiu, Y., Wang, Y., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.370 · Cited by 118
Li, Y., Ye, Y., Feng, B., & Qi, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26107 · Cited by 117
Li, W., & Melton, D. W. (2011) · Oncogene · doi:10.1038/onc.2011.426 · Cited by 116
Saha, S., Mukherjee, S., Khan, P., Kajal, K., Mazumdar, M., Manna, A., Mukherjee, S., De, S., Jana, D., Sarkar, D. K., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1360 · Cited by 116
Liao, H., Bai, Y., Qiu, S., Zheng, L., Huang, L., Liu, T., Wang, X., Liu, Y., Xu, N., Yan, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3563 · Cited by 113
MiR‐489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway
Jiang, L., He, D., Yang, D., Chen, Z., Pan, Q., Mao, A., Cai, Y., Li, X., Xing, H., Shi, M., et al. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.024 · Cited by 112
XU, R., Liu, S., CHEN, H., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4497 · Cited by 111
Genistein-Inhibited Cancer Stem Cell-Like Properties and Reduced Chemoresistance of Gastric Cancer
Huang, W., Wan, C. C., Luo, Q., Huang, Z., & 罗琪 (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033432 · Cited by 109
Tung, S.-L., Huang, W.-C., Hsu, F.-C., Yang, Z.-P., Jang, T.-H., Chang, J.-W., Chuang, C.-M., Lai, C.-R., & Wang, L. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.25 · Cited by 109
Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells
Wang, T., Wei, J., Qian, X., Ding, Y., Yu, L., & Liu, B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.12.004 · Cited by 106
USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51‐AKT signaling
Luo, K., Li, Y., Yin, Y., Li, L., Wu, C., Chen, Y., Nowsheen, S., Hu, Q., Zhang, L., Lou, Z., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695669 · Cited by 106
Zhang, P., Zhang, P., Shi, B., Zhou, M., Jiang, H., Zhang, H., Pan, X., Gao, H., Sun, H., & Li, Z. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.526 · Cited by 105
Jang, J.-W., Song, Y., Kim, S.-H., Kim, J.-S., Kim, K. M., Choi, E. K., Kim, J., & Seo, H. R. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.023 · Cited by 101
Koster, R., Timmer‐Bosscha, H., Bischoff, R., Gietema, J. A., & de Jong, S. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.33 · Cited by 100
MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53
Lakshmanan, I., Salfity, S., Seshacharyulu, P., Rachagani, S., Thomas, A., Das, S., Majhi, P. D., Nimmakayala, R. K., Vengoji, R., Lele, S. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2530 · Cited by 99
Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia
Piya, S., Andreeff, M., & Borthakur, G. M. (2016) · Autophagy · doi:10.1080/15548627.2016.1245263 · Cited by 97
Li, J., Liu, H., Yu, J., & Yu, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3356 · Cited by 96
Zhang, J., Zhang, H.-D., Yao, Y., Zhong, S., Zhao, J. H., & Tang, J. H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430191 · Cited by 94
Izumiya, M., Kabashima, A., Higuchi, H., Igarashi, T., Sakai, G., Iizuka, H., Nakamura, S., Adachi, M., Hamamoto, Y., Funakoshi, S., et al. (2012) · PubMed · Cited by 94
Wang, T., Ning, K., Lu, T., Sun, X., Jin, L., Qi, X., Jin, J., & Hua, D. (2016) · Cancer Science · doi:10.1111/cas.13150 · Cited by 92
泉谷, 幹. (2013) · Medical Entomology and Zoology · Cited by 90
Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells
Yang, X., Wang, J., Zhou, Y., Wang, Y., Wang, S., & Zhang, W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.030 · Cited by 88
Exosome-derived microRNAs contribute to prostate cancer chemoresistance
Li, J., Yang, X., Guan, H., Mizokami, A., Keller, E. T., Xu, X., Liu, X., Tan, J., Hu, L., Lü, Y., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3560 · Cited by 87
Lv, L. L., Liu, H.-G., Dong, S., Yang, F., Wang, Q., Guo, G., Pan, Y., & Zhang, X. (2016) · Tumor Biology · doi:10.1007/s13277-015-4755-6 · Cited by 84
Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin via autophagy
Dong, X., Wang, Y., Zhou, Y., Wen, J., Wang, S., & Shen, L. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.87 · Cited by 84
Grass, G. D., Dai, L., Qin, Z., Parsons, C. H., & Toole, B. P. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00013-7 · Cited by 83
Mitochondrial dynamics regulating chemoresistance in gynecological cancers
Kong, B., Tsuyoshi, H., Orisaka, M., Shieh, D., Yoshida, Y., & Tsang, B. K. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12883 · Cited by 80
Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer
Niu, D.-G., Peng, F., Zhang, W., Guan, Z., Zhao, H.-D., Li, J.-L., Wang, K.-L., Li, T., Zhang, Y., Zheng, F.-M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2894 · Cited by 79
Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer
Wang, L., Mosel, A., Oakley, G. G., & Peng, A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0448 · Cited by 78
Mani, J., Vallo, S., Rakel, S., Antonietti, P., Gessler, F. A., Blaheta, R. A., Bartsch, G. C., Michaelis, M., Cinatl, J. J., Haferkamp, A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1239-4 · Cited by 77
Bourguignon, L., Wong, G., & Shiina, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700021 · Cited by 76
Liu, S., Sun, J. P., Cai, B., Xi, X., Yang, L., Zhang, Z., Feng, Y., & Sun, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-4848-x · Cited by 75
MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
Zhao, H., Yu, X., Ding, Y., Zhao, J., Wang, G., Wu, X., Jiang, J., Peng, C., Guo, G., & Cui, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10736 · Cited by 75
Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1
Jung, J.-G., Shih, I., Park, J. T., Gerry, E., Kim, T. H., Ayhan, A., Handschuh, K., Davidson, B., Fader, A. N., Selleri, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0980 · Cited by 72
Yang, L., Yan, Y., Kang, R., Yang, M., Xie, M., Wang, Z., Tang, D., Zhao, M., Liu, L., Zhang, H., et al. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.616962 · Cited by 71
Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer
Liu, Y., Hsu, H., Tseng, K.-C., Chen, H., & Chen, S. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.08.001 · Cited by 70
LTAN, B., Yokobori, T., Ide, M., Bai, T., Yanoma, T., Kimura, A., Kogure, N., Suzuki, M., Bao, P., Mochiki, E., et al. (2016) · Anticancer Research · doi:10.21873/anticanres.11094 · Cited by 70
Li, Y., Huang, S., Li, Y., Zhang, W., He, K., Zhao, M., Lin, H., Li, D., Zhang, H., Zheng, Z., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5254-0 · Cited by 68
AP-1-Dependent miR-21 Expression Contributes to Chemoresistance in Cancer Stem Cell-Like SP Cells
Misawa, A., Katayama, R., Koike, S., Tomida, A., Watanabe, T., & Fujita, N. (2010) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504010x12828372551759 · Cited by 65
miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer
Fu, Q., Cheng, J., Zhang, J., Zhang, Y., Chen, X., Luo, S., & Xie, J. (2016) · Oncology Reports · doi:10.3892/or.2016.5259 · Cited by 60
Cardenas, C., Montagna, M. K., Pitruzzello, M. C., Lima, E., Mor, G., & Alvero, A. B. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1339-x · Cited by 59
Wu, Q., Wang, R., Yang, Q., Hou, X., Chen, S., Hou, Y., Chen, C., Yang, Y. F., Miele, L., Sarkar, F. H., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1471 · Cited by 57
Chen, H., Zhang, W., Cheng, X., Guo, L., Xie, S., Yuan-fang Ma, A., Guo, N., & Shi, M. (2017) · Cancer Science · doi:10.1111/cas.13275 · Cited by 56
Gabrielson, M., Björklund, M., Carlson, J. W., & Shoshan, M. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107109 · Cited by 54
Yao, J., Huang, A., Zheng, X., Liu, T., Lin, Z., Zhang, S., Yang, Q., Zhang, T., & Ma, H. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2302-5 · Cited by 52
Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.
Santos, J. C., Ribeiro, M. L., Sarian, L. O., Ortega, M. M., & Derchain, S. (2016) · PubMed · Cited by 52
Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance.
Hehlgans, S., & Cordes, N. (2011) · Europe PMC (PubMed Central) · Cited by 51
Kuroda, H., Takeno, M., Murakami, S., Miyazawa, N., Kaneko, T., & Ishigatsubo, Y. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.03.015 · Cited by 50
Sun, Y., Guan, Z., Liang, L., Cheng, Y., Zhou, J., Li, J., & Xu, Y. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3256 · Cited by 47
You, M., Chen, Y.-J., Chong, Q., Wu, M., Pandey, V., Chen, R., Liu, L., Ma, L., Wu, Z.-S., Zhu, T., et al. (2017) · OncoTarget · doi:10.18632/oncotarget.16950 · Cited by 47
Zhang, Y., Zeng, S., Ma, J., Deng, G., Qu, Y., Guo, C., & Shen, H. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0387-y · Cited by 46
Exosomes-mediate Micrornas Transfer In Breast Cancer Chemoresistance Regulation
Santos, Santos, J. C., Ribeiro, M. L., de Lima, M. A., Sarian, L. O., Otávio, L., Ortega, Ortega, M. M., Derchain, S., & Françoise, S. (2016) · Americanae (AECID Library) · Cited by 45
PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations
Yao, Z., Jones, A. W. E., Fassone, E., Sweeney, M. G., Lebiedzińska, M., Suski, J. M., Wieckowski, M. R., Tajeddine, N., Hargreaves, I. P., Yasukawa, T., et al. (2012) · Oncogene · doi:10.1038/onc.2012.259 · Cited by 44
Sh, H., Wang, C., Zj, H., Liu, F., Cw, X., Xl, L., & Chen, G.-Q. (2016) · PubMed · Cited by 44
High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance
Wang, L., Zhang, H., Sun, M., Yin, Z., & Qian, J. (2015) · Oncology Reports · doi:10.3892/or.2015.4278 · Cited by 42
Feng, S., Zheng, Z., Feng, L., Yang, L., Chen, Z., Lin, Y., Gao, Y., & Yide, C. (2016) · Oncology Reports · doi:10.3892/or.2016.5154 · Cited by 41
Dong, Q., Fu, L., Zhao, Y., Tan, S., & Wang, E. (2017) · Oncotarget · doi:10.18632/oncotarget.15001 · Cited by 41
Hoang, B. Q., Zhu, L. X., Shi, Y., Frost, P., Yan, H., Sharma, S., Sharma, S. P., Goodglick, L., Dubinett, S. M., & Lichtenstein, A. K. (2006) · Blood · doi:10.1182/blood-2005-09-3926 · Cited by 40
Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells
Seubwai, W., Vaeteewoottacharn, K., Kraiklang, R., Umezawa, K., Okada, S., & Wongkham, S. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14424348426071 · Cited by 32
Zhang, Y., Hu, Y., Wang, J.-L., Yao, H., Wang, H., Liang, L., Li, C., Shi, H., Chen, Y., Fang, J.-Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.152 · Cited by 32
Guay, D. R. P., Evoy, A.-A., Paquet, É. R., Garand, C., Bachvarova, M., Bachvarov, D. R., & Lebel, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.04.011 · Cited by 31
Kadera, B. E., Toste, P. A., Wu, N., Li, L., Nguyen, A. H., Dawson, D. W., & Donahue, T. R. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0610 · Cited by 30
Zhu, X., Zou, S., Zhou, J., Zhu, H., Zhang, S., Shang, Z., Ding, W., Wu, J., & Chen, Y. (2016) · Oncology Reports · doi:10.3892/or.2016.4549 · Cited by 28
Tang, J., Guo, F., Du, Y., Liu, X., Qin, Q., Liu, X., Yin, T., Jiang, L., & Wang, Y. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2898 · Cited by 27
CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells
Xiong, L., Ding, L., Ning, H., Wu, C., Fu, K., Wang, Y., Zhang, Y., Liu, Y., & Zhou, L. (2016) · Oncotarget · doi:10.18632/oncotarget.10252 · Cited by 27
Wang, X., Bao, Y., Dong, Z., Chen, Q., Guo, H., Ziang, C., & Shao, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16931 · Cited by 27
Role of the ERK1/2 pathway in tumor chemoresistance and tumor therapy
Liu, Q.-H., Shi, M., Sun, C., Bai, J., & Zheng, J. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.11.076 · Cited by 21
Körber, M. I., Staribacher, A., Ratzenböck, I., Steger, G. G., & Mader, R. M. (2016) · PubMed · Cited by 20
Cited by
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Vodenkova, S., Buchler, T., Cervena, K., Veskrnova, V., Vodicka, P., & Vymetalkova, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107447 · Cited by 956
Wang, L., Cho, K. B., Li, Y., Tao, G., Xie, Z., & Guo, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225758 · Cited by 605
Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-02198-8 · Cited by 565
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Metadata
- Authors
- Zheng, H.-C.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-07-06
- Volume
- 8
- Issue
- 35
- Pages
- 59950-59964
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2729738977
- Cited by
- 624
- References
- 112
- FWCI
- 24.23
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.